November 18, 2013 / 2:33 PM / in 4 years

MARKET PULSE- Boeing, Microsoft, Sony, Tyson Foods, Supervalu

(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s); for the Morning News Call newsletter, link.reuters.com/nex49s)

U.S. stocks were set to inch up at the open on Monday, with the Dow and S&P set to extend their records as trading continues to focus on economic stimulus from the Federal Reserve and other central banks. S&P 500 futures rose 3 points, Dow Jones industrial average futures 55 points and Nasdaq 100 futures 4 points.

** APPLE INC, Friday close $524.99

The iPhone maker has bought PrimeSense, an Israeli maker of chips that enable three-dimensional (3D) machine vision, for $345 million, the Calcalist financial newspaper reported on Sunday without citing sources.

** BOEING CO, Friday close $136.08, up 3.5 pct premarket

The U.S. planemaker said at the Dubai Airshow on Sunday that it had received orders worth $100 billion at list prices - its largest ever - for 259 of its new 777 jets.

For a Factbox on orders, click

** JPMORGAN CHASE & CO, Friday close $54.87, up 1 pct premarket

The biggest U.S. bank by assets said on Friday it agreed to pay $4.5 billion to settle claims by investors who lost money on mortgage-backed securities before the collapse of the U.S. housing market.

** MICROSOFT CORP MSFT.O, Friday close $37.84, down 1.5 pct premarket

** SONY CORP, Friday close $18.50, up 2.3 pct premarket

BofA Merrill downgraded Microsoft’s stock to “underperform” from “neutral”, according to the Theflyonthewall.com.

Rival Sony Corp said on Sunday it had sold 1 million units of its new PlayStation 4 gaming console in the first 24 hours that it was available in the United States and Canada, ahead of Microsoft’s Xbox One launch on Nov. 22.

** TYSON FOODS INC, Friday close $28.77, up 4 pct premarket

The largest U.S. meat processor reported a better-than-expected rise in quarterly profit, helped by higher chicken sales and a rebound in its beef business.

** INTERCLOUD SYSTEMS INC, Friday close $9.46, up 49 pct premarket

Shares of the cloud and consulting services company continued their gain for the second day. The stock soared about 206 percent on Friday after the company's revenue rose five-fold to $16.2 million, helped by acquisitions and organic growth. (link.reuters.com/zuf74v)

** CATALYST PHARMACEUTICAL PARTNERS INC, Friday close $1.60, up 26 pct premarket

The specialty pharmaceutical company said a medical journal had accepted a research paper on a preclinical study that showed its experimental drug had the potential to suppress a form of epilepsy in infants. The preclinical study on rats also showed that the drug was well tolerated.

Catalyst also said it planned to start an early stage study to evalute the safety and tolerability of multiple doses of the drug, known as CPP-115, in the first half of 2014.

** JINKOSOLAR HOLDING CO LTD, Friday close $29.5, up 9.2 premarket

The Chinese solar panel maker reported a second straight quarterly profit on Monday, boosting hopes of a recovery in the sector as panel prices hold firm after declining for nearly four years.

** MAZOR ROBOTICS LTD, Friday close $18.65, down 6.6 percent premarket

The company reported a larger-than-expected loss in the third quarter as sales of its spine surgery robot in the United States fell and its operating expenses increased.

** CANADIAN SOLAR INC, Friday close $31.91, up 6 pct premarket

A renewable energy project fund managed by DIF will buy four solar power plants totaling 40 megawatts from Canadian Solar in Ontario, the solar company said on Monday. Construction is expected to start this year, while commercial operation from the plants is expected in 2014. The companies did not disclose the value of the deal.

** BLYTH INC, Friday close $12.00, up 5 pct premarket

The candle maker named its chief operating officer Robert Goergen Jr as chief executive. Blyth’s founder Robert Goergen Senior will continue to serve as executive chairman of the board.

Last week, Blyth rejected an unsolicited acquisition proposal from direct seller CVSL Inc.

** MECHEL OAO, Friday close $2.32, up 5 pct premarket

Russian state-controlled bank VTB has agreed to join other creditors in restructuring mining group Mechel’s $9.6 billion debt, a source close to VTB said on Saturday.

** SUPERVALU INC, Friday close $63.52, down 5 pct premarket

Goldman Sachs cut its rating on the supermarket operator’s stock to “sell” from “neutral” as it expects the company to be hurt by increased competition and higher costs as a result of the Affordable Care Act.

** CELL THERAPEUTICS INC, Friday close $1.87, up 7.5 pct premarket

The drug maker said it could spend up to $96 million through mid-2017 to develop its drug pacritinib to treat two forms of blood cancer. The company said it expects to get $67 million in cash milestone payments through 2015 from its deal with Baxter International Inc, which would offset some of its expenses.

The two companies agreed on Friday to jointly develop and market the drug in a deal that could fetch Cell Therapeutics up to $362 million.

** RENESOLA LTD, Friday close $4.7, up 2 pct premarket

The Chinese solar panel maker said it would deliver more than 178,000 panels for a 53.5 megawatt power project in Southern Texas. The project is expected to be completed in 2016.

** SALESFORCE.COM INC, Friday close $57.31, up 2 pct premarket

Shares rose ahead of the cloud software company third-quarter results after the bell. The company is expected to beat estimates, according to Thomson Reuters StarMine data. Salesforce is reporting the first full three-month period since it acquired email marketing company ExactTarget for $2.5 billion.

** NVIDIA CORP, Friday close $16.17, down 2 pct premarket

Morgan Stanley cut its rating on the graphics chipmaker’s stock to “underweight,” saying that the stock seems to be pricing in substantial earnings improvement that is still uncertain.

The analysts also said the value of patent royalty the company got from Intel Corp through a cross-licensing agreement was less than their expectations and there was little prospect of renewal of the agreement.

** ALPHA NATURAL RESOURCES INC, Friday close $8.08, down 3 pct premarket

Analysts at Citi Investment Research cut their rating on the coal miner’s stock to “sell” from “neutral”, according to Theflyonthewall.com.

** BONA FILM GROUP LTD, Friday close $6.13, down 3.7 pct premarket

Brokerage Cowen & Co cut its rating on the company’s stock to “market perform” from “outperform” and lowered its target price to $5 from $6 after the film distributor on Thursday reported third-quarter revenue below analysts’ average expectations.

** PERRIGO CO, Friday close $153.13, up 0.5 pct premarket

Ireland’s Elan won approval from shareholders on Monday to complete the sale of the company to U.S. drugmaker Perrigo, clearing the way for the deal to be completed by the end of the year.

** ROYAL BANK OF SCOTLAND, Friday close $10.63, up 1 pct premarket

The bank said it was in talks to sell its retail investor products and equity derivatives business, as it slims down its investment bank. Several industry sources have identified BNP Paribas, France’s biggest bank, as front-runner to buy the business.

** INTERACTIVE BROKERS GROUP INC, Friday close $24.02, down 1.3 pct premarket

Analysts at Keefe, Bruyette & Woods downgraded the online broker’s stock to ‘market perform’ from ‘outperform’.

“We believe that the brokerage business is sufficiently big enough to consistently outweigh the market-making noise and FX translation issues when valuing the company and stock, but that most of this revaluation has now occurred,” the analysts said in a note to clients.

** DIEBOLD INC, Friday close $30.58, up 1.3 percent premarket

KeyBanc Capital Markets raised its rating on the ATM and voting machines maker to “buy” from “hold”, according to Theflyonthewall.com.

** WASHINGTON POST CO, Friday close $654.59

The company is changing its name to Graham Holdings Co after it sold the Washington Post newspaper to Amazon.com Inc founder Jeff Bezos.

** CAREFUSION CORP, Friday close $39.18

The medical device maker said it will buy General Electric Co healthcare’s respiratory care and anesthesiology products business, Vital Signs, for $500 million.

** ABBVIE INC, Friday close $48.44

The company said a late-stage trial of its experimental oral hepatitis C treatment showed about 96 percent of patients had no detectable levels of the virus after 12 weeks.

** SANOFI, Friday close $53.96

The French drugs group has halted all clinical trials and canceled plans to seek regulatory approval of fedratinib, a drug in late-stage development against rare bone marrow cancers, due to safety concerns.

** GOLDCORP INC, Friday close $24.34

** BARRICK GOLD, Friday close $18.07

Canadian gold miners Goldcorp and Barrick Gold are looking to sell their jointly owned Marigold mine in Nevada, according to sources familiar with the situation.

** FREEPORT-MCMORAN COPPER & GOLD INC, Friday close $36.83

The U.S. miner has agreed to pay nearly a third more in annual processing charges to China’s leading copper smelters, likely increasing the pressure on rival BHP to raise its own offer on the charges.

** AMERICAN INTERNATIONAL GROUP INC, Friday close $49.3

Taiwanese tycoon Richard Tsai and Chinese financier Xiao Jianhua are in talks to help fund a long-delayed $4.2 billion purchase of the U.S. insurer’s aircraft-leasing unit, Bloomberg reported.

** DISH NETWORK CORP, Friday close $50.94

Bankrupt wireless communications firm LightSquared Inc has filed a lawsuit accusing Dish Network and its chairman, Charles Ergen, of improperly trying to take control of LightSquared’s broadband spectrum.

** PETROFAC LTD, Friday close $11.57

The energy services group has warned it expects little or no growth next year, putting in doubt a 2015 target which has been an important focus for investors and sending its shares down more than 15 percent.

** RHOEN-KLINIKUM, Friday close $12.72

Germany’s Rhoen-Klinikum should buy up its own shares and cancel them to return cash to shareholders from the sale of hospitals to rival Fresenius, Chairman and founder Eugen Muench told a German newspaper. (Compiled by Natalie Grover; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below